Healthy Subjects
Conditions
Brief summary
Characterization of an unexpected venodilative effect of higher L-NMMA-doses in dorsal human hand veins.
Interventions
DRUGL-NMMA(drug)
Sponsors
Technische Universität Dresden
Study design
Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
MALE
Age
18 Years to 45 Years
Healthy volunteers
Yes
Inclusion criteria
* healthy subjects
Exclusion criteria
* any relevant disease
Countries
Germany
Outcome results
None listed